Back to Companies
Indaptus Therapeutics, Inc.
INDPNasdaqCIK: 0001857044
Over the 11 most recent insider filings, Indaptus Therapeutics, Inc. (INDP) has seen activity from 9 distinct insiders — no open-market buying or selling. Meckler Jeffrey A (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $151.1K by Meckler Jeffrey A. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$267.1K
Purchases
$0
Sales
$0
Unique Insiders
9
Recent Insider Trades
11 loaded
| Apr 20 | INDP Indaptus Therapeutics, Inc. | Lu Qinglai | Director | Other | $0 |
| Apr 2 | INDP Indaptus Therapeutics, Inc. | SINO LION VENTURES Ltd | 10% Owner | Other | $0 |
| Apr 2 | INDP Indaptus Therapeutics, Inc. | Yao Yun | 10% Owner | Other | $0 |
| Apr 2 | INDP Indaptus Therapeutics, Inc. | Dai Junyi | Chief Executive Officer | Other | $0 |
| Feb 26 | INDP Indaptus Therapeutics, Inc. | McMurdo Matthew Charles | Director | Other | $0 |
| Jan 12 | INDP Indaptus Therapeutics, Inc. | NATAN DAVID | Director | Other | $0 |
| Jan 22 | INDP Indaptus Therapeutics, Inc. | NATAN DAVID | Director | Award | $67.3K |
| Jan 22 | INDP Indaptus Therapeutics, Inc. | Ben-Tzvi Avraham | Director | Grant | $48.8K |
| Dec 23 | INDP Indaptus Therapeutics, Inc. | Lazar David E. | Co-Chief Executive Officer | Other | $0 |
| Dec 23 | INDP Indaptus Therapeutics, Inc. | Ben-Tzvi Avraham | Director | Other | $0 |
| Jul 29 | INDP Indaptus Therapeutics, Inc. | Meckler Jeffrey A | Chief Executive Officer, Director | Grant | $50.4K |
11 filings